In order to investigate the potential molecular pathways involved in the induction of IL-8 expression by ETBF/BFT, we pre-treated CRC cell lines with antagonists to Stat3 (Stattic) and β-catenin (B21) prior to incubation with ETBF or BFT. The gene discussed is STAT3; the disease is colorectal carcinoma.